A phase II trial of lenvatinib plus pembrolizumab in patients (pts) with endometrial or ovarian carcinosarcoma.
Year: 2026
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Sminu Bose, Corbyn Mbock Nchako, Qin Zhou, Alexia Iasonos, Ashley Rodriguez, Mauline Onsombi, Kara Pierro, Korri Sagoes, Natalie Solberg, Viktoriya Paroder, Maria M. Rubinstein, Seth M. Cohen, Martee Leigh Hensley, Chrisann Kyi, William P. Tew, Ying L. Liu, Alison M. Schram, Britta Weigelt, Carol Aghajanian, Vicky Makker
Institution: Memorial Sloan Kettering Cancer Center
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7162525522
Cites:
Cited by:
Related to: